Real-world learning curve analysis of colorectal endoscopic submucosal dissection: a large multicenter study.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
08 2020
Historique:
received: 10 01 2019
accepted: 21 08 2019
pubmed: 5 9 2019
medline: 22 5 2021
entrez: 5 9 2019
Statut: ppublish

Résumé

The current status of colorectal endoscopic submucosal dissection (ESD) performed by endoscopists without colorectal ESD experience is unknown. This study evaluated the quality of colorectal ESD performed by endoscopists without colorectal ESD experience. We retrospectively examined the outcomes of 420 consecutive patients with 427 superficial colorectal tumors (male/female, 251/169; mean age, 69 years) who underwent ESD. The procedures were performed by 31 endoscopists without colorectal ESD experience using needle knife-type devices at 13 hospitals from October 2008 to June 2017. Cases were divided into the first and second phases according to the experience of the endoscopist: the first phase included the first 20 cases and the second phase included case 21 and beyond. We also identified factors associated with en bloc resection failure. Rates of colonic tumors, laterally spreading tumors of the non-granular type, poor scope operability, and severe submucosal fibrosis for the first phase were significantly lower than those for the second phase. The en bloc resection rates for the first and second phases were 93% and 96%, respectively. The factors associated with en bloc resection failure were poor scope operability (odds ratio [OR] 2.6; 95% confidence interval [CI] 1.0-6.5), severe submucosal fibrosis (OR 6.5; 95% CI 2.6-15.9), and the first 20 cases (OR 3.4; 95% CI 1.2-10.1). Inexperienced endoscopists should initially perform colorectal ESD for tumors without severe submucosal fibrosis under good scope operability for at least 20 cases.

Sections du résumé

BACKGROUND
The current status of colorectal endoscopic submucosal dissection (ESD) performed by endoscopists without colorectal ESD experience is unknown. This study evaluated the quality of colorectal ESD performed by endoscopists without colorectal ESD experience.
METHODS
We retrospectively examined the outcomes of 420 consecutive patients with 427 superficial colorectal tumors (male/female, 251/169; mean age, 69 years) who underwent ESD. The procedures were performed by 31 endoscopists without colorectal ESD experience using needle knife-type devices at 13 hospitals from October 2008 to June 2017. Cases were divided into the first and second phases according to the experience of the endoscopist: the first phase included the first 20 cases and the second phase included case 21 and beyond. We also identified factors associated with en bloc resection failure.
RESULTS
Rates of colonic tumors, laterally spreading tumors of the non-granular type, poor scope operability, and severe submucosal fibrosis for the first phase were significantly lower than those for the second phase. The en bloc resection rates for the first and second phases were 93% and 96%, respectively. The factors associated with en bloc resection failure were poor scope operability (odds ratio [OR] 2.6; 95% confidence interval [CI] 1.0-6.5), severe submucosal fibrosis (OR 6.5; 95% CI 2.6-15.9), and the first 20 cases (OR 3.4; 95% CI 1.2-10.1).
CONCLUSION
Inexperienced endoscopists should initially perform colorectal ESD for tumors without severe submucosal fibrosis under good scope operability for at least 20 cases.

Identifiants

pubmed: 31482350
doi: 10.1007/s00464-019-07104-2
pii: 10.1007/s00464-019-07104-2
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3344-3351

Auteurs

Kazuki Boda (K)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3 Kasumi Minami-ku, Hiroshima, Japan.

Shiro Oka (S)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3 Kasumi Minami-ku, Hiroshima, Japan. oka4683@hiroshima-u.ac.jp.

Shinji Tanaka (S)

Department of Endoscopy, Hiroshima University Hospital, 1-2-3 Kasumi Minami-ku, Hiroshima, Japan.

Shinji Nagata (S)

Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan.

Masaki Kunihiro (M)

Department of Internal Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.

Toshio Kuwai (T)

Department of Gastroenterology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.

Yuko Hiraga (Y)

Department of Endoscopy, Hiroshima Prefectural Hospital, Hiroshima, Japan.

Akira Furudoi (A)

Department of Gastroenterology, JA Hiroshima General Hospital, Hiroshima, Japan.

Koichi Nakadoi (K)

Department of Gastroenterology, Onomichi General Hospital, Hiroshima, Japan.

Hideharu Okanobu (H)

Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, Japan.

Tomohiro Miwata (T)

Department of Gastroenterology, Chugoku Rosai Hospital, Hiroshima, Japan.

Shiro Okamoto (S)

Department of Gastroenterology, Kure Kyosai Hospital, Hiroshima, Japan.

Kazuaki Chayama (K)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH